Long-term Evaluation of Stem Cell Transplant Patients

This study is for patients who have received an allogeneic (donor) stem cell transplant at the NIH Clinical Center. It aims to provide ongoing care and evaluation for these patients, especially those who are at least three years out from their transplant. Researchers will monitor your response to treatment, check for any return of your disease, and look for any long-term effects from the transplant. The goal is to ensure consistent care and gather important information about the long-term health of transplant survivors. This study is for individuals between 7 and 80 years old who meet specific transplant criteria.

Study design
This is an observational study, meaning researchers will monitor patients over time without providing new experimental treatments. It plans to enroll 1000 participants.
What's involved
You would generally have clinic visits every 12 months, which may include physical exams, eye exams, and blood and urine tests.
Compensation
Not stated in the trial record.
Follow-up
This study involves ongoing evaluation and care for transplant patients over time.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00106925

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Recruiting
Not specifiedAges 7–80Observational
National Heart, Lung, and Blood Institute (NHLBI)
~1,000 participants
Updated 2026-08-27 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Assure consistency of care over time for transplant patients such that outcome data can be meaningfully accrued.
Measured over Ongoing
Graft-versus-leukemia
Graft vs Host Disease
Graft Rejection
1 sites across 1 states
Maryland1
  • Richard W Childs, M.D. · PRINCIPAL_INVESTIGATOR · National Heart, Lung, and Blood Institute (NHLBI)

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

With an experimental allogeneic stem cell transplant on a NHLBI HB protocol
With a standard of care allogeneic stem cell transplant on an NHLBI protocol
Selectively, when the allogenic transplant was conducted outside the NIH, but the subject has a special condition of interest to the research team
  • Assure consistency of care over time for transplant patients such that outcome data can be meaningfully accrued.Ongoing

    monitor late effects of treatment and provide or recommend appropriate management